Take action today
A cure for Herpes Simplex Virus (HSV-1 and HSV-2) is urgently needed for the 6 billion people globally living with HSV. Herpes is not benign. We need a cure today because patients are waiting.
Learn more about Herpes Cure Advocacy and our goals. There needs to be greater emphasis on cure, treatment and prevention as no public health intervention or national strategy exists.
Despite herpes being highly common, it is a traumatic diagnosis. We believe because Herpes Simplex is stigmatized so intensely, there have been no centralized advocacy efforts to date, and no cure.
Read the latest news in clinical research and medical breakthroughs for the cure, treatment and prevention of Herpes. The clinical pipeline is gaining moment. We need a cure today, because patients are waiting.
Herpes infection increases risk of HIV acquisition more than any other STI. Herpes also impacts brain health – the extent to which remains unknown.
THE LATEST NEWS
Chinese company BDGene from Shanghai continues to lead in the global race for a herpes keratitis cure. We reported on its progress – which it has published in…
Welcome to the latest clinical pipeline for Herpes Simplex Virus types 1 +2, the Herpes Cure Pipeline 3.0. Here we’ve updated, removed, and added new projects…
Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it’s the only thing that ever has.Margaret Mead